Clinical trial
ICTUS Study: International Citicoline Trial on Acute Stroke
NCT00331890 · Ferrer Internacional S.A., Industry · Terminated
Key facts
| NCT number | NCT00331890 |
|---|---|
| Title | ICTUS Study: International Citicoline Trial on Acute Stroke |
| Official title | Citicoline in the Treatment of Acute Ischemic Stroke. An International Randomized Multicenter Placebo-controlled Study |
| Acronym | ICTUS |
| Lead sponsor | Ferrer Internacional S.A., Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Stroke, Cerebral Infarction |
| Intervention type | Drug |
| Interventions | Citicoline, Placebo |
| Enrollment | 2,298 |
| Start date | Oct 1, 2006 |
| Primary completion | Feb 1, 2012 |
| Completion | Mar 1, 2012 |
| First posted | May 31, 2006 |
| Last update posted | Jun 20, 2012 |
| Countries | Germany, Portugal, Spain |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: